PrimeRFP SCOUT · Federal Contract Recompete Brief

75N91022F00007THIS COVID TASK ORDER supports NIAIDS — Leidos Biomedical Research, Inc

Leidos Biomedical Research, Inc holds $2.1B across 186 federal awards, concentrated at Department of Health and Human Services (HHS). This PIID sits alongside 5 related awards under parent 75N91019D00024. Competition previously drew 2 offers. Recompete timing centers on the Sep 29, 2026 PoP end — agencies typically plan 12–18 months ahead.

Nih Nci
Awarding office
Leidos Biomedical Research, Inc
Recipient
Sep 29, 2026
PoP end
$38.1M
Obligated
541715
NAICS
AN12
PSC
2 bidders on last award

Watch this recompete

One email. No account. We ping you if the window moves.

Score my position vs Leidos Biomedical Research, Inc — $90

Contract facts

Federal
Contract number75N91022F00007
Also listed as75N91019D00024-75N91022F00007
AgencyNih Nci
Awarding officeNih Nci
IncumbentLeidos Biomedical Research, Inc
UEIHV8BH9BPG8Y9
NAICS541715
PSCAN12
Parent IDIQ / IDV75N91019D00024
Place of performanceFREDERICK, MD
PoP end (current)Sep 29, 2026
PoP end (w/ options)Sep 29, 2027
Obligated$38.1M

THIS COVID TASK ORDER SUPPORTS NIAIDS NEED TO CONDUCT A TRIAL OF AN ADDITIONAL DOSE VACCINE TO EVALUATE VARIANT VACCINE… is a federal award for Nih Nci held by Leidos Biomedical Research, Inc. Estimated value $38.1M ($38.1M obligated). Current period of performance ends Sep 29, 2026 (potential Sep 29, 2027). Last award drew 2 bidders. Place of performance: FREDERICK, MD.

THIS COVID TASK ORDER SUPPORTS NIAIDS NEED TO CONDUCT A TRIAL OF AN ADDITIONAL DOSE VACCINE TO EVALUATE VARIANT VACCINES ALONE OR IN COMBINATION IN AN IMMUNOLOGICALLY DIVERSE POPULATION. THE WORK INCLUDES THE ABILITY TO PROVIDE THE MANAGEMENT, OVERS

Recompete timing

Public
Expiring in 40 days

Current PoP ends Sep 29, 2026 (40 days remaining). Agencies typically plan 12–18 months ahead — at 1.3 months out, that window is already open. The buying decision is likely already in motion.

Incumbent footprint

Public record

Leidos Biomedical Research, Inc$2.1B obligated across 186 awards (firm-wide, all agencies).

Sole agency: Department of Health and Human Services (HHS)
Department of Health and Human Services (HHS)$2.1B · 100% of firm total
Open full company profile

Related awards

Same parent · incumbent
75N91021F00013
ENABLING NCI CLINICAL & RESEARCH DATA SHARING
Department of Health and Human Services (HHS) · LEIDOS BIOMEDICAL RESEARCH, INC.
$81.1M
Aug 31, 2026
75N91020F00026
DEVELOPMENT OF TARGET CHARACTERIZATION METHODS FOR NOVEL CANCER MARKERS
Department of Health and Human Services (HHS) · LEIDOS BIOMEDICAL RESEARCH, INC.
$56.5M
May 25, 2027
75N91020F00009
ON BEHALF OF NIAID-DCR, FACILITATE THE CONDUCT OF TWO, RANDOMIZED TRIALS AS DETAILED BELOW…
Department of Health and Human Services (HHS) · LEIDOS BIOMEDICAL RESEARCH, INC.
$89.6M
Jul 31, 2028
75N91020F00025
DCR IS REQUESTING THE SERVICES OF LEIDOS BIOMEDICAL RESEARCH, INC. TO INITIATE MANAGEMENT,…
Department of Health and Human Services (HHS) · LEIDOS BIOMEDICAL RESEARCH, INC.
$97.5M
Sep 24, 2028
75N91019F00139
MD NET
Department of Health and Human Services (HHS) · LEIDOS BIOMEDICAL RESEARCH, INC.
$163.5M
Sep 29, 2028

Query this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP

More in SCOUT
Size up the competition →Research the incumbent →

Frequently asked questions

What is contract 75N91022F00007?

75N91022F00007 (THIS COVID TASK ORDER supports NIAIDS) is a Nih Nci award with an estimated value of $38.1M, currently held by Leidos Biomedical Research, Inc. Figures are USASpending-sourced public-record facts plus SCOUT recompete analysis.

Which office awarded 75N91022F00007?

Nih Nci awarded 75N91022F00007 to Leidos Biomedical Research, Inc.

Who is the incumbent on 75N91022F00007?

Leidos Biomedical Research, Inc is the incumbent with $2.1B across 186 related awards in SCOUT’s public footprint. The current period of performance ends Sep 29, 2026.

When does Leidos Biomedical Research, Inc’s 75N91022F00007 come up for recompete?

SCOUT tracks a period-of-performance end of Sep 29, 2026. Actual solicitation timing can shift with extensions, bridges, or consolidations.

Data: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.

Data as of · refreshed monthlyLatest procurement action
Sources: USASpending, FPDS, SAM.gov · Public-record facts + SCOUT analysis shown above; personalized scoring in SCOUT.
primerfp.com/intel/contract/75N91022F00007